Bausch + Lomb Corporation

NYSE:BLCO

15.91 (USD) • At close September 6, 2024
Bedrijfsnaam Bausch + Lomb Corporation
Symbool BLCO
Munteenheid USD
Prijs 15.91
Beurswaarde 5,598,656,132
Dividendpercentage 0%
52-weken bereik 13.16 - 17.915
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Brenton L. Saunders J.D.
Website https://www.bausch.com

An error occurred while fetching data.

Over Bausch + Lomb Corporation

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact

Vergelijkbare Aandelen

Penumbra, Inc. logo

Penumbra, Inc.

PEN

203.73 USD

Perrigo Company plc logo

Perrigo Company plc

PRGO

27.69 USD

Teladoc Health, Inc. logo

Teladoc Health, Inc.

TDOC

7.51 USD

Encompass Health Corporation logo

Encompass Health Corporation

EHC

91.66 USD

Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc.

DNA

5.65 USD

Inspire Medical Systems, Inc. logo

Inspire Medical Systems, Inc.

INSP

196.88 USD

Globus Medical, Inc. logo

Globus Medical, Inc.

GMED

69.99 USD

Doximity, Inc. logo

Doximity, Inc.

DOCS

36.34 USD

AptarGroup, Inc. logo

AptarGroup, Inc.

ATR

152.38 USD

Envista Holdings Corporation logo

Envista Holdings Corporation

NVST

17.44 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)